| Title |
Analysis of the Cost-Effectiveness of Liquid Biopsy to Determine Treatment Change in Patients with Her2-Positive Advanced Breast Cancer in Colombia
|
|---|---|
| Published in |
ClinicoEconomics and Outcomes Research: CEOR, February 2020
|
| DOI | 10.2147/ceor.s220726 |
| Pubmed ID | |
| Authors |
Diana Sánchez-Calderón, Adriana Pedraza, Catalina Mancera Urrego, Aurelio Mejía-Mejía, Ana Lorena Montealegre-Páez, Sandra Perdomo |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | 50% |
| France | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
| Scientists | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 64 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 10 | 16% |
| Other | 5 | 8% |
| Researcher | 5 | 8% |
| Unspecified | 3 | 5% |
| Student > Postgraduate | 3 | 5% |
| Other | 10 | 16% |
| Unknown | 28 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 12 | 19% |
| Biochemistry, Genetics and Molecular Biology | 6 | 9% |
| Unspecified | 3 | 5% |
| Business, Management and Accounting | 3 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Other | 9 | 14% |
| Unknown | 29 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2020.
All research outputs
#16,642,835
of 25,462,162 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#312
of 525 outputs
Outputs of similar age
#278,643
of 473,211 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#5
of 8 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 525 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 473,211 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.